18 January 2022
Young adults have a stronger immune response to vaccines than older adults, and results from COVID-19 vaccine studies have suggested lower doses of the Pfizer or Moderna COVID-19 vaccines may give as good an immune response in young adults as higher doses.
11 January 2022
People with severe alcohol disorder were able to abstain from drinking alcohol for longer when treated with low doses of ketamine combined with psychological therapy, a clinical trial has found.
10 January 2022
People who have already been infected by some common cold viruses are less likely to get COVID, according to new results from a study funded by the NIHR.
10 January 2022
Early stage research suggests a new version of an immunotherapy called CAR T-cell therapy has fewer toxic side effects and is effective for longer in adults with relapsed B-cell acute lymphoblastic leukaemia (B-ALL), a group who previously had few treatment options available.
07 January 2022
Leading scientists at the National Institute for Health Research (NIHR) have been recognised in the Queen’s New Year Honours List for outstanding contributions to health and social care.
06 January 2022
New research has shown that psilocybin, a psychedelic drug isolated from the Psilocybe mushroom, can be safely administered at doses of either 10mg or 25mg to up to six participants at the same time.
04 January 2022
The first results of an early trial of a multivariant COVID-19 vaccine booster, launched in September 2021 and supported by the NIHR, has released positive data.
01 January 2022
Professor Nick Lemoine receives CBE for services to clinical research in Queen’s New Year Honours
22 December 2021
The differences in COVID-19 infection risk between ethnic minority healthcare workers and their white colleagues is likely due to home and work factors rather than biology, according to the largest and most detailed study on the subject.
17 December 2021
The world's first plant-based COVID-19 vaccine from Medicago and GSK is 75.3% effective against preventing COVID-19 of any severity (from the Delta variant), finds an NIHR-supported study.
16 December 2021
People who were hospitalised with COVID-19 and continued to experience symptoms at five months show limited further recovery one year after hospital discharge, a key finding of the Post-hospitalisation COVID-19 study (PHOSP-COVID) has revealed.
14 December 2021
The UK Clinical Research Recovery, Resilience and Growth Programme (RRG) has today published an update detailing the key milestones that have been achieved in the 6 months since the publication of “The Future of UK Clinical Research Delivery” 2021/22 implementation plan.
08 December 2021
A first-of-its-kind clinical trial to investigate the effectiveness of new COVID-19 oral antiviral treatments - which can be safely taken at home - has begun enrolling participants today.
07 December 2021
Following up first doses of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines with second doses of the Moderna and Novovax jabs will generate robust immune responses against COVID-19.
03 December 2021
Six COVID-19 vaccines are safe and boost immunity for people who have had two doses of AstraZeneca or Pfizer-BioNTech, results from the UK-wide COV-BOOST trial show.
01 December 2021
Children with poorly controlled asthma are up to six times more likely to be hospitalised with COVID-19 than those without the condition, a study conducted in Scotland suggests.
01 December 2021
The National Institute for Health Research has published its first diversity data report.
30 November 2021
A new NIHR-supported study is setting out to investigate why COVID-19 vaccines can lead to rare instances of blood clotting with low platelets known as thrombotic thrombocytopenia syndrome (TTS).
30 November 2021
A same-day test has cut the time taken to identify secondary infections in intensive care COVID-19 patients from four days to within 24 hours.
26 November 2021
A new study of over 220,000 patients has found that those who contract COVID-19 are at a greater risk of fatigue and sleep problems.
25 November 2021
The Preg-CoV Study is comparing the use of different approved vaccines and boosters, at different schedule intervals for pregnant women.
25 November 2021
Dr Jonathan Rodrigues has been awarded Outstanding Clinical Radiology Researcher of 2021 by The Royal College of Radiologists (RCR) and the National Institute for Health Research.
23 November 2021
The NIHR has awarded nearly £20 million through its global health funding programme to help tackle multiple long-term conditions.
23 November 2021
NIHR-funded researchers from the University of Oxford will undertake the world’s first cancer prevention trial in adults with Li Fraumeni Syndrome (LFS).
19 November 2021
Researchers have launched the largest ever stem cell clinical trial for children with the severe skin condition Epidermolysis Bullosa (EB) - a rare genetic condition which causes the skin to blister and tear at the slightest touch.
